Live News EQUITY M impact Jun 25, 2026, 08:31 PM UTC

CSTL Outperforms MIA

CSTL's DecisionDx-Melanoma's i31-SLNB outperforms MIA Nomogram in identifying patients who may safely forgo sentinel lymph node biopsy

SQUAWKNEWS Updated Jun 25, 2026, 08:31 PM UTC

CSTL - DecisionDx®-Melanoma's i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy